User profiles for Melanie R Nicol
 | Melanie Rae NicolUniversity of Minnesota Verified email at unc.edu Cited by 3504 |
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19
…, CP Skipper, AA Nascene, MR Nicol… - New England journal …, 2020 - Mass Medical Soc
Background Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the …
respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the …
Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial
Background: No effective oral therapy exists for early coronavirus disease 2019 (COVID-19).
Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in …
Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in …
Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly emerging viral
infection causing coronavirus disease 2019 (COVID-19). Hydroxychloroquine and …
infection causing coronavirus disease 2019 (COVID-19). Hydroxychloroquine and …
Hydroxychloroquine as pre-exposure prophylaxis for coronavirus disease 2019 (COVID-19) in healthcare workers: a randomized trial
…, AS Bangdiwala, MR Nicol… - Clinical Infectious …, 2021 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly
emerging virus causing the ongoing coronavirus disease 2019 (COVID-19) pandemic with no …
emerging virus causing the ongoing coronavirus disease 2019 (COVID-19) pandemic with no …
Pharmacogenomics of COVID-19 therapies
A new global pandemic of coronavirus disease 2019 (COVID-19) has resulted in high mortality
and morbidity. Currently numerous drugs are under expedited investigations without well-…
and morbidity. Currently numerous drugs are under expedited investigations without well-…
Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial
Background Identifying new antifungals for cryptococcal meningitis is a priority given the
inadequacy of current therapy. Sertraline has previously shown in vitro and in vivo activity …
inadequacy of current therapy. Sertraline has previously shown in vitro and in vivo activity …
Finding the dose for hydroxychloroquine prophylaxis for COVID‐19: the desperate search for effectiveness
Hydroxychloroquine is an antimalarial drug being tested as a potential treatment for the novel
coronavirus disease 2019 (COVID‐19) pandemic caused by the severe acute respiratory …
coronavirus disease 2019 (COVID‐19) pandemic caused by the severe acute respiratory …
Safety of hydroxychloroquine among outpatient clinical trial participants for COVID-19
SM Lofgren, MR Nicol, AS Bangdiwala… - Open forum …, 2020 - academic.oup.com
Background Use of hydroxychloroquine in hospitalized patients with coronavirus disease
2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns. …
2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns. …
A systematic review of treatment and outcomes of pregnant women with COVID-19—a call for clinical trials
KA Pastick, MR Nicol, E Smyth, R Zash… - Open forum …, 2020 - academic.oup.com
Background Data pertaining to COVID-19 in pregnancy are limited; to better inform clinicians,
we collated data from COVID-19 cases during pregnancy and summarized clinical trials …
we collated data from COVID-19 cases during pregnancy and summarized clinical trials …
Phase I EnACT trial of the safety and tolerability of a novel oral formulation of amphotericin B
Amphotericin B deoxycholate (AMB) has substantial toxicities. A novel encochleated
amphotericin B deoxycholate (cAMB) formulation has oral bioavailability, efficacy in an animal …
amphotericin B deoxycholate (cAMB) formulation has oral bioavailability, efficacy in an animal …
